Delayed Hypersensitivity Reactions (Archived)
- PMID: 30085565
- Bookshelf ID: NBK519023
Delayed Hypersensitivity Reactions (Archived)
Excerpt
Coombs and Gel classified type IV hypersensitivity reaction (HR) as a delayed hypersensitivity reaction (DHR), which takes more than 12 hours to develop. Typically the maximal reaction time occurs between 48 to 72 hours. Antibodies do not mediate DHR; it is mediated by T cells that cause an inflammatory reaction to either exogenous or autoantigens. This HR to exogenous antigens involves T cells and also antigen-presenting cells (APC) such as macrophages and dendritic cells, all produce cytokines that stimulate a local inflammatory response in a sensitized individual. The DHR to autoantigens can be seen in type 1 diabetes mellitus, which is an autoimmune disease that results from autoimmune cell-mediated destruction of insulin-secreting pancreatic beta cells. DHR cannot be transferred from an animal to another by means of antibodies or serum. However, it can be transferred by T cells, particularly CD4 Th1 cells, but it is progressively lost in individuals with HIV/AIDS. Antigen-presenting cells (APC) such as Langerhans cells engulf process and present antigens to antigen-specific T cells that become sensitized. Cytokines produced by keratinocytes, APC, and T cells recruit antigen-nonspecific T cells and macrophages to participate in a local inflammatory reaction.
There are three variants of delayed hypersensitivity as listed below and their maximal reaction time appears in brackets:
Contact (48 to 72 hours)
Tuberculin (48 to 72 hours)
Granulomatous (21 to 28 days)
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Barailler H, Milpied B, Chauvel A, Claraz P, Taïeb A, Seneschal J, Darrigade AS. Delayed hypersensitivity skin reaction to hydroxychloroquine: Successful short desensitization. J Allergy Clin Immunol Pract. 2019 Jan;7(1):307-308. - PubMed
-
- Pelzer PT, Mutayoba B, Cobelens FGJ. BCG vaccination protects against infection with Mycobacterium tuberculosis ascertained by tuberculin skin testing. J Infect. 2018 Oct;77(4):335-340. - PubMed
-
- Galvan-Blasco P, Guilarte M, Cardona V, Labrador-Horrillo M, Sala-Cunill A, Gil-Serrano IJ, Luengo O. Delayed drug hypersensitivity to bortezomib: Desensitization and tolerance to its analogue carfilzomib. Allergy. 2019 Jul;74(7):1384-1386. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials